Categories

Introducing the Next Generation Automated Synthetic Biology Workstation Codex DNA recently announced the commercial release of the BioXp™ 9600 system – a fully automated, high-throughput benchtop platform for synthetic biology workflows designed to empower scientists to accelerate discovery of new…

We’re thrilled to announce the partnership with MBC Biolabs, a premier biotech incubator in the Bay Area. Under the terms of the collaboration, MBC Biolabs will leverage Codex DNA’s BioXp™ system to empower entrepreneurs in life sciences research with the…

In San Diego, scientists at ag biotech startup Cellibre are looking to replace traditional agriculture for producing high-value ingredients. One of their first targets is the highly valuable cannabinoid market, which they believe can be disrupted by producing natural, high-quality,…

BCC sits down with Jason Lehmann, PhD, from Codex DNA, Inc. in San Diego to talk about Codex DNA’s mission of applying breakthroughs in synthetic biology automation solutions. BCC podcast host Clara Mouawad and Jason talk about Codex DNA’s recent…

Synthetic biology has advanced rapidly through the years as biologists, physicists, and engineers have continued their efforts to deliver new solutions to global healthcare, agriculture, manufacturing, and environmental challenges. As rapidly as the field is evolving, it’s important to appreciate…

As we are quickly approaching the end of 2020, we’re taking a moment to look back at the year — all 237 months of it. While we hope to never go through another year like this one, we can’t help…

There’s celebrating in the halls — and virtual halls — of Codex DNA. We are truly honored that our new BioXp™ 3250 system was selected as one of the year’s best innovations by The Scientist. This is a very prestigious…

When it comes to improving life, there is no science more exciting than synthetic biology. The more we learn from reading the DNA or RNA code of every organism on this planet, the better equipped we are to make significant…